System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Malgorzata Wasniewska is an expert in Endocrinology at Hospital University Hospital "G. Martino " (Italy). As of October 2026, ScienceLeadR ranks Malgorzata Wasniewska in the top 1% of experts worldwide for Hypothyroidism, Urogenital Abnormalities and Obesity. Malgorzata Wasniewska has authored 391 publications, the most recent in 2026, and is an investigator in 5 clinical trials, 3 of them ongoing. SLR score: 1,245 (community average: 125). How the SLR is computed.

LeadR Profile

Malgorzata Wasniewska Hospital University Hospital "G. Martino " Italy
1 245 ScienceLeadR Reputation 1245

Unlock

Register Login
Network Map

Endocrinology

Subspecialties: Pediatrics - Nutrition - Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2000 - 2026
Source: PubMed

University of Messina

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 391

Citations

Citations: 5 205 1st author: 60 Last author: 111 Unique author: 5

Main journals

J Endocrinol Invest 35
Front Endocrinol (Lausanne) 32
Eur J Endocrinol 23
Ital J Pediatr 22
Horm Res Paediatr 21

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Growing up with Klinefelter syndrome: challenges of care in children and adolescents and patients advocacy.
PMID 42803872 — hormones, adolescent, klinefelter syndrome, child		Endocrine20260
Neuroimaging Abnormalities and Genotype-Phenotype Correlations in Noonan Syndrome: A Multicenter Cohort Study.
PMID 42657773 — endocrinology, brain neoplasms, neuroimaging, noonan syndrome, brain, neoplasms, phenotype, cohort studies, genotype, child		J Clin Endocrinol Metab20260
Cardiovascular Involvement of Multisystem Inflammatory Syndrome in Children: A Multicentric Observational Study on Mid- and Long-term Follow-up with Cardiovascular Imaging.
PMID 42615034 — ventricular dysfunction, left, echocardiography, child		J Cardiovasc Echogr20260
Uric acid to high density lipoprotein-cholesterol ratio as a potential biomarker of comorbidities in youth with obesity.
PMID 42409680 — comorbidity, uric acid, insulin, homeostasis, lipoproteins, cardiovascular diseases, lipoproteins, hdl, biomarkers, diet, cholesterol, obesity, cholesterol, hdl		Nutr Metab Cardiovasc Dis20260
The case for primary prevention of obesity in the era of GLP-1 therapies.
PMID 42403918 — glucagon-like peptide 1, drug therapy, obesity, primary prevention, therapeutics		Lancet Reg Health Eur20260

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 3
Phase 3 1
Phase 4 1

By status:

Completed 2
Recruiting 2
Not yet recruiting 1

By type:

Observational 3
Interventional 2

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 4

Main Topics

Cohort/Consortium Investigators 5

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Phase 3 Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children with Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
2025-523079-44-00 — genes, turner syndrome, growth, safety, gestational age, hormones, adolescent, human growth hormone, growth hormone, child		Phase 3Not yet recruiting2026
National Multicentre Study on Lipid Profile in Noonan Syndrome and Related Disorders Trends by Age Gender and Genotype
NCT07464821 — noonan syndrome, genotype, lipids		N/ARecruiting2025
Institution of an Italian Multicenter Database of Patients Affected by Hypoparathyroidism or Pseudohypoparathyroidism
NCT06645899 — endocrinology, hypoparathyroidism, incidence, data collection, pathology, pseudohypoparathyroidism, prevalence, pseudopseudohypoparathyroidism, therapeutics, male, bone and bones		N/ARecruiting2024

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS